Pathophysiologic significance of left ventricular hypertrophy in dilated cardiomyopathy

K Iida1, M el Sersi, K Fujieda

  • 1Department of Internal Medicine, University of Tsukuba, Japan.

Clinical Cardiology
|September 1, 1996
PubMed

Insights

Patients with dilated cardiomyopathy and left ventricular hypertrophy show improved systolic reserve and require less norepinephrine during exercise. This suggests a mechanism for their better prognosis in DCM.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Heart Failure Research

Background:

  • Dilated cardiomyopathy (DCM) patients with left ventricular hypertrophy (LVH) exhibit a better prognosis.
  • The underlying pathophysiological mechanisms for this improved outcome remain unclear.

Purpose of the Study:

  • To investigate the pathophysiological significance of LVH in DCM.
  • To clarify why LVH is associated with a better prognosis in DCM patients.

Main Methods:

  • Isoproterenol infusion echocardiography was performed in 17 DCM patients.
  • Plasma epinephrine and norepinephrine levels were measured at rest and during exercise.
  • Patients were categorized into LVH-positive (LVH+) and LVH-negative (LVH-) groups based on ventricular wall thickness.

Main Results:

  • Fractional shortening response to isoproterenol was significantly higher in the LVH+ group compared to the LVH- group.
  • Plasma norepinephrine levels at peak exercise were significantly lower in the LVH+ group than in the LVH- group.
  • No significant difference in resting fractional shortening or plasma norepinephrine levels was observed between groups.

Conclusions:

  • Patients with DCM and LVH possess greater systolic reserve, indicated by a superior response to isoproterenol.
  • Lower plasma norepinephrine levels are sufficient to activate the myocardium during exercise in DCM patients with LVH.
  • These findings suggest that enhanced systolic reserve and altered catecholamine response in LVH+ DCM patients contribute to their better clinical prognosis.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...